Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
9.07
-1.68 (-15.63%)
At close: Apr 28, 2026, 4:00 PM EDT
9.04
-0.03 (-0.33%)
After-hours: Apr 28, 2026, 4:24 PM EDT
Artiva Biotherapeutics Market Cap
Artiva Biotherapeutics has a market cap or net worth of $224.18 million as of April 28, 2026. Its market cap has increased by 400.09% in one year.
Market Cap
224.18M
Enterprise Value
168.64M
1-Year Change
400.09%
Ranking
Category
Stock Price
$9.07
Market Cap Chart
Since the IPO on July 19, 2024, Artiva Biotherapeutics's market cap has increased from $176.76M to $224.18M, an increase of 26.83%. That is a compound annual growth rate of 14.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 265.70M | 152.34% |
| Dec 31, 2025 | 105.30M | -56.99% |
| Dec 31, 2024 | 244.84M | 38.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Coherus Oncology | 269.88M |
| Alector | 265.97M |
| Eledon Pharmaceuticals | 263.22M |
| SAB Biotherapeutics | 247.37M |
| Sol-Gel Technologies | 244.62M |
| Arcturus Therapeutics Holdings | 244.15M |
| Adagene | 243.81M |
| Orchestra BioMed Holdings | 241.69M |